BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB. 00:10:00
Dr. Martin Welschof is the CEO of BioInvent International AB, a Swedish company specializing in the development of first-in-class immuno-modulatory antibodies for cancer treatment. He has a robust scientific and executive background in biotechnology. Before joining BioInvent, Dr. Welschof was the CEO of Opsona Therapeutics and a co-founder and managing director of Affitech A/S in Oslo and Copenhagen. Additionally, he served as the Director of Technology at Axaron Bioscience.
